This site is intended for health professionals only!

Published on 26 February 2009

Share this story:

Sanofi completes Zentiva takeover


Paris-based Sanofi-Aventis has completed its takeover of Czech pharmaceutical company Zentiva in a deal that makes it the world’s 11th-largest generic-drugs manufacturer.

It now owns 94% of Zentiva, which makes and sells generic drugs in Central and Eastern Europe, including products for pain, cardiovascular diseases and central nervous system disorders.

Sanofi’s initial takeover bid of 1.65 billion euros (£1.48 billion) last June was rejected by Zentiva’s management in July. A revised offer of 1.8 billion euros (£1.6 billion) in September was accepted.

Sanofi-Aventis began building its stake in Zentiva more than two years ago. It said that shareholders representing 70% of Zentiva’s outstanding capital had tendered their shares in the latest offer.

Copyright Press Association 2009


Most read

Latest Issue

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Share this story: